Aglepristone in Cats (Felis) | Vetlexicon
felis - Articles

Aglepristone

ISSN 2398-2950


Synonym(s): RU 534

Introduction

Name

  • Aglepristone.

Class of drug

  • Progesterone receptor antagonist.

Description

Chemical name

  • (8S,11R,13S,14S,17R)-11-(4-dimethylaminophenyl)-17-hydroxy-13-methyl-17-[(Z)-prop-1-enyl]-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one

Molecular formula

  • C29H37NO2

Molecular weight

  • 431.60958

Physical properties

  • Clear yellow oily solution.

Storage requirements

  • Shelf life of 3 years.
  • Once opened must be used within 28 days and discarded if discoloration occurs.
  • As the available veterinary formulation contains no antibacterial preservative, swab the opening's membrane with suitable disinfectant each time before withdrawing the dose to be administered.
  • Protect the bottle from light.

Uses

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Administration

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Pharmacokinetics

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Precautions

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Withdrawal Periods

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Adverse Reactions

Subscribe To View

This article is available to subscribers.

Try a free trial today or contact us for more information.

Further Reading

Publications

Refereed papers

  • Recent references from PubMed and VetMedResource.
  • Georgiev P, Bostedt H, Goericke-Pesch S, Dimitrov M, Petkov P, Stojanthev K, Tsoneva V, Wehrend A (2010) Induction of abortion with aglepristone in cats on day 45 and 46 after mating. Reprod Domest Anim 45 (5), e161-167 PubMed.
  • Goericke-Pesch S, Plamen,  Georgiev P (2010) Prevention of pregnancy in cats using aglepristone on days 5 and 6 after mating. Theriogenology 74 (2), 304-310 PubMed.
  • Jurka P, Max A (2009)Treatment of fibroadenomatosis in 14 cats with aglepristone - changes in blood parameters and follow-up. Vet Rec 165 (22), 657-660 PubMed.
  • Nak D, Nak Y, Tuna B (2009) Follow-up examinations after medical treatment of pyometra in cats with the progesterone-antagonist aglepristone. JFMS 11(6), 499-502 PubMed.
  • Favre R N, Gimenez F, Stornelli M C, Tittarelli C M, Savignone C A, de la Sota R L, Sternelli M A (2007) Induction of abortion in queens by administration of aglepristone (Alizin): Preliminary results. Theriogenology 68, 492-518; abstr.014.
  • Fieni F, Martal J, Marnet P G, Siliart B, Guittot F (2006) Clinical, biological and hormonal study of mid-pregnancy termination in cats with aglepristone. Theriogenology 66 (6-7), 1721-1728. Epub 2006 Mar 24. Erratum In: Theriogenology 67 (7), 1305 PubMed.
  • Georgiev P & Wehrend A (2006) Mid-gestation pregnancy termination by the progesterone antagonist aglepristone in queens.Theriogenology 65 (7), 1401-1406 PubMed.
  • Georgiev P, Wehrend A, Dimitrov M, Vasilev N, Yotov S, Bostedt H (2006) Effect of progesterone receptor antagaonist aglepristone administered on days 5 and 6 after mating in queens.Reprod Domest Anim 41 (Suppl 1), 1-41 (abstr).
  • Meisl D, Hubler M, Arnols S (2003) Treatment of fibroepithelial hyperplasia (FEH) of the mammary gland in the cat with progesterone antagonist aglepristone (Alizine). Schweiz Arch Tierheilkd 145 (3), 130-136 PubMed.
  • Goerlinger S, Kooistra H S, van den Broek A, Okkens A C (2002) Treatment of fibroadenomatous hyperplasia in cats with aglepristone. J Vet Intern Med 16 (6), 710-713.
  • Wehrend A, Hospes R, Gruber A D (2001)Treatment of feline mammary fibroadenomatous hyperplasia with a progesterone-antagonist. Vet Rec 148 (11), 346-347 PubMed.

Other sources of information

  • BSAVA Small Animal Formulary. Ramsey I (2017) 9th edn.